Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics and Inhibrx Enter an Exclusive Partnership for GMP Manufacturing 2018-09-11 08:38
WuXi Biologics Selected into the Hang Seng HK 35 Index 2018-08-30 10:08
WuXi Biologics Reports Robust 2018 Interim Results 2018-08-20 20:25
WuXi Biologics Commenced Process Validation in MFG2 2018-07-31 07:55
WuXi Biologics Announced Successful Completion of the First cGMP Run in MFG3 2018-07-25 07:55
WuXi Biologics and Immune Pharmaceuticals Announce Late-Phase Development and Manufacturing Partnership for a First-In-Class Monoclonal Antibody 2018-07-09 22:00
WuXi Biologics and Harbour BioMed Announce Strategic Development and Manufacturing Partnership 2018-06-25 07:55
WuXi Biologics Initiated Construction of a State-of-the-Art Integrated ADC Solution Center 2018-06-20 08:03
WuXi Biologics to Invest $60 Million to Establish a Biologics Production Facility in the United States 2018-06-11 08:34
WuXi Biologics and Tsinghua University Innovation Center for Immune Therapy Sign MOU and Announce Strategic Partnership 2018-05-30 08:34
WuXi Biologics to Invest S$80 Million to Establish a Biologics Manufacturing Facility in Singapore 2018-05-22 18:34
WuXi Biologics and Bioasis Announce Initial Strategic Collaboration for the Development and Manufacturing of Bioasis' Lead Investigational Candidate to Treat Brain Cancer 2018-05-21 20:30
WuXi Biologics to Build an Integrated Biologics Development, Clinical and Commercial Manufacturing Center in Shijiazhuang 2018-05-16 18:09
WuXi Biologics to Invest €325 Million to Build Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland 2018-04-30 20:41
WuXi Biologics Wins CMO Leadership Award from Life Science Leader Magazine 2018-04-17 08:13
WuXi Biologics to Install Industry's Largest Single-Use Bioreactor from ABEC at its New Commercial Manufacturing Facility 2018-03-21 08:18
WuXi Biologics Reports Remarkable 2017 Annual Results: Revenue up 63.7% to a Record High of RMB1,618.8 Million 2018-03-19 20:41
WuXi Biologics and Adagene Announce Strategic Development and Manufacturing Partnership 2018-03-09 11:43
WuXi Biologics Receives Asia's CMO of 2017 from BioPharma Industry Awards 2018-03-06 14:11
WuXi Biologics Announces Positive Profit Alert 2018-03-05 17:48
1 5 6 7 8 9